Peter Huang, Global President - Data Center & Thermal Management at bp Castrol, explains why AI isn't just consuming more ...

Disability progression in relapsing MS tends to follow one of four distinct patterns, according to a new study.

The combined Company will move forward as Decoy Therapeutics, Inc. and trade on the NASDAQ Stock Market under the ticker “DCOY” effective in ...

In this article, we examine ongoing challenges shaping target-based drug discovery and highlight how new technologies and ...

WIRED spoke with DeepMind’s Pushmeet Kohli about the recent past—and promising future—of the Nobel Prize-winning research ...

As the healthcare industry emerges from the pilot purgatory of artificial intelligence experimentation, leading venture ...

Doctors treating ICU patients on ventilators face a constant challenge regarding nutrition. Now, an AI system can help.

Explore the top 7 API automation testing tools for software developers in 2025, their features, strengths, pricing, and how they enhance API reliability and performance.

Kalaris Therapeutics offers differentiated approach to neovascular AMD with its lead candidate TH103. Click here to read my ...

Pathophysiologic biomarkers for chronic spontaneous urticaria (CSU) are emerging, which can help better target therapies for ...

Jedi Digital Marketing Hong Kong has announced a continued emphasis on refining its digital marketing framework, reflecting broader shifts in how organizations manage online visibility, information ...

SACRAMENTO, Calif., Dec. 18, 2025 /PRNewswire/ -- Lunai Bioworks Inc. (NASDAQ: LNAI), an AI-driven pharmaceutical discovery company, was featured in International Business Times in a year-end analysis ...